维拉帕米治疗心律失常疗效及安全性研究

来源 :临床合理用药杂志 | 被引量 : 0次 | 上传用户:ys331223
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的观察维拉帕米治疗心律失常的疗效及安全性。方法选取医院收治的室上性心律失常患者120例为研究对象,随机分为观察组和对照组,每组60例。对照组采用普罗帕酮治疗,观察组采用维拉帕米治疗,观察2组患者的临床疗效及不良反应发生情况。结果观察组总有效率为95.0%,高于对照组的84.9%(P<0.05)。观察组不良反应发生率为1.7%,低于对照组的8.3%(P<0.05)。结论对心律失常患者的治疗,应掌握好个体化用药原则,维拉帕米可治疗老年快速室上性心律失常。 Objective To observe the efficacy and safety of verapamil in the treatment of arrhythmia. Methods A total of 120 patients with supraventricular arrhythmia admitted to the hospital were selected as study subjects and randomly divided into observation group and control group with 60 cases in each group. The control group was treated with propafenone. The observation group was treated with verapamil. The clinical efficacy and adverse reactions of the two groups were observed. Results The total effective rate in the observation group was 95.0%, higher than that in the control group (84.9%, P <0.05). The incidence of adverse reactions in the observation group was 1.7%, which was lower than 8.3% in the control group (P <0.05). Conclusion For the treatment of patients with arrhythmia, the principle of individualized medication should be mastered. Verapamil may be used to treat the elderly patients with rapid supraventricular arrhythmias.
其他文献
介绍张葆青教授运用柴胡桂枝干姜汤加减治疗小儿抽动障碍的思路及临证经验。张葆青教授认为小儿抽动障碍的病因以"风"为主,包括"内风"和"外风",常兼有"痰""湿""瘀""虚"等病因
本文首先给出了总风险组合的尾部在险价值(TVaR)以及指数尾部在险价值(EVaR)的具体形式,并且根据保单数目分为两种情况:二维和多维情况,同时保单组合以及信用组合的风险贡献值
以三文鱼肉为原料,通过复合酶解的方法获得海洋蛋白低聚肽,对其理化性质、氨基酸组成、分子质量分布等方面进行分析;从羟基自由基、DPPH自由基和超氧阴离子自由基清除活性及
回 回 产卜爹仇贱回——回 日E回。”。回祖 一回“。回干 肉果幻中 N_。NH lP7-ewwe--一”$ MN。W;- __._——————》 砧叫]们羽 制作:陈恬’#陈川个美食 Back to yield
会议
应用KeyMath算术诊断测验对西安市125名学生进行研究发现(1)对照组与实验组学生在KeyMath得分及年级等值等方面均有显著性差异;(2)实验组学生的数学能力弱势随年级增高呈加重